L. Cupelli

发表

Safety and tolerability of a 6‐week course of oseltamivir prophylaxis for seasonal influenza in children

K. Reisinger, R. Dutkowski, D. Shu, 2012, Influenza and other respiratory viruses.

Issues of geologically-focused situational awareness in robotic planetary missions: Lessons from an analogue mission at Mistastin Lake impact structure, Labrador, Canada

G. Osinski, L. Preston, I. Antonenko, 2013 .

The Secondary Structure of the R Region of a Murine Leukemia Virus Is Important for Stimulation of Long Terminal Repeat-Driven Gene Expression

J. Lenz, S. Okenquist, A. Trubetskoy, 1998, Journal of Virology.

Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy

D. Dieterich, S. Passe, S. Mauss, 2004, AIDS.

Improved outcomes in patients with hepatitis C with difficult‐to‐treat characteristics: Randomized study of higher doses of peginterferon α‐2a and ribavirin

D. Nelson, T. Morgan, M. Fried, 2008, Hepatology.

Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells

J. Lenz, J. Berman, J. E. Losardo, 1989, Journal of virology.

A second-generation YAC contig map of human chromosome 12.

K. Montgomery, J. Leblanc-Straceski, B. Renault, 1995, Nature.

Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences

J. Lenz, L. Cupelli, 1991, Journal of virology.

Assignment of the human myogenic factors 5 and 6 (MYF5, MYF6) gene cluster to 12q21 by in situ hybridization and physical mapping of the locus between D12S350 and D12S106.

R. Kucherlapati, J. Leblanc-Straceski, B. Renault, 1996, Cytogenetics and cell genetics.

The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter

M C Hsu, L A Cupelli, M. Hsu, 1995, Journal of virology.

Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19

John D. Davis, Y. Soo, G. Yancopoulos, 2021, medRxiv.

LB4. Casirivimab and Imdevimab for Treatment of Hospitalized Patients With COVID-19 Receiving Low Flow or No Supplemental Oxygen

John D. Davis, Y. Soo, G. Yancopoulos, 2021, Open Forum Infectious Diseases.

A Series of Robotic and Human Analogue Missions in Support of Lunar Sample Return

John E. Moores, Kip V. Hodges, Marwan Hussein, 2012 .

Lunar Analogue Mission: Overview of the Site Selection Process at Mistastin Lake Impact Structure, Labrador, Canada

G. Osinski, L. Preston, I. Antonenko, 2011 .

Safety and Tolerability of Double-Dose and Duration Oseltamivir Regimens in Patients with H1N1pdm09

R. Dutkowski, T. Burgess, L. Cupelli, 2014 .